7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
We understand how high the stakes are with gene therapy programs, and that nothing is standard about the study design, study conduct or regulatory process. Join us a the Cell & Gene Meeting On the Mesa to explore the technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering and broader regenerative medicine technologies.
We understand that every cell and gene therapy is unique, involving a complicated regulatory approval process full of unknowns.
Veristat has assembled an extraordinary global team of experts in this field to help your study avoid errors in design, data collection, or analysis. We’re here to help you get your compound to market faster and positively impact patients’ lives.
Whether you are looking for a partner throughout the entire clinical development process or need additional functional support, Veristat scientific-minded experts can help you achieve success with the following:
Request a meeting with Denis Wilson or Jim Barrio on the event's Partnering One System. Log in here: https://informaconnect.com/cell-gene-meeting-on-the-mesa/login/
Visit the conference website to register or learn more:
https://www.meetingonthemesa.com/
7 min read
May 20, 2026 Veristat Blog
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...